Could a common supplement help hearts pump better?
NCT ID NCT07367724
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a medicine called ademetionine in 44 adults with a heart condition that blocks blood flow. Participants will take either the medicine or a placebo for 16 weeks. Researchers will check if it helps with exercise, symptoms, and heart function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (OHCM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fuwai Hospital
RECRUITINGBeijing, China
-
The First Affiliated Hospital of Xinjiang Medical University
NOT_YET_RECRUITINGXinjiang, China
-
Zhongshan Hospital, Shanghai Medical College of Fudan University
RECRUITINGShanghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New heart drug aficamten challenges standard Beta-Blocker in major trial
- Heart drug mavacamten under the microscope: Real-World study launches
- Heart drug mavacamten shows promise in Real-World study
- Gene test may personalize heart drug dosing
- New pill aims to help heart patients breathe easier and move more
- Heart drug mavacamten under real-world safety watch in japan